Montelukast Prescribing at THE DUNSTAN PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,083
Total Quantity
32.4K
NHS Cost
£1.6K
vs National Avg
+58.2%
THE DUNSTAN PARTNERSHIP prescribed 1,083 items of Montelukast over the last 12 months at a cost of £1,581 to the NHS. This is 58.2% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
92
Jun 2026
99
Jun 2026
97
Jun 2026
98
Jun 2026
84
Jun 2026
94
Jun 2026
86
Jun 2026
89
Jun 2026
92
Jun 2026
73
Jun 2026
94
Jun 2026
85
Prescribing Details
| Total Items | 1,083 |
|---|---|
| Total Quantity | 32,410 |
| Total NHS Cost | £1,581 |
| Presentations | 4 different forms |
| vs National Average | +58.2% |
Montelukast Prescribing Comparison
| This practice | 1,083 items |
|---|---|
| National average per practice | 685 items |
| Difference | +58.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.